Switching from Zepbound to Wegovy? What you need to know

Switching from Zepbound to Wegovy happens for all kinds of reasons: insurance changes, side effects, or a shift in health goals — but should you do it?

Here's what the research says about how the two medications compare, when making the switch makes sense, and what to expect if you do.

Yes, switching from Zepbound (tirzepatide) to Wegovy (semaglutide) is possible, as long as your healthcare provider thinks it's the right move for you.

Both are GLP-1 medications approved for weight loss, so they work in similar ways. But they're not interchangeable, and the switch isn't always straightforward.

Zepbound targets two hormone receptors (GLP-1 and GIP), while Wegovy targets just one, which is part of why the two medications don't always produce identical results.

This is something your healthcare provider can help you with. They’ll be able to look at your current dose, how you've responded so far, and your health goals before advising on next steps.

See if you qualify

Both medications work for weight management alongside healthy lifestyle changes. But if you're thinking about switching, it helps to know exactly how they differ.

How they work

Wegovy mimics GLP-1, a gut hormone that slows down digestion, reduces appetite, and helps regulate blood sugar levels. 

Zepbound does all of that, too, but it also activates a second hormone pathway called GIP. That dual action may be why Zepbound tends to produce stronger weight-loss results on average. 

A few more key differentiators:

• Wegovy is available as a weekly subcutaneous (under-the-skin) injection and a daily oral tablet. The injection comes in doses ranging from 0.25 mg to 7.2 mg weekly, while the pill comes in doses ranging from 1.5 mg to 25 mg daily.

• Zepbound is just a weekly subcutaneous injection that comes in doses ranging from 2.5 mg to 15 mg weekly. 

Weight loss outcomes

On paper, Zepbound produces greater weight loss than Wegovy. In a 2025 trial, people with obesity (and without diabetes) lost an average of 20.2% of their body weight on Zepbound, compared to 13.7% on Wegovy over 72 weeks.

Even though it’s less than Zepbound’s 20.2%, that 13.7% is still a meaningful amount of weight to lose, and some people simply respond better to Wegovy. It's not always predictable in advance, and can be another reason why people switch from one to another.

A caveat worth noting is that the 2025 trial compared the maximum Zepbound dose (15 mg) with the highest Wegovy doses available at the time (1.7 mg or 2.4 mg). A new, higher dose was approved in early 2026. People in trials lost an average of 18.7% of their body weight on Wegovy HD 7.2 mg, compared with 15.6% on 2.4 mg and 3.9% with placebo over 72 weeks.

Overall, Zepbound may lead to more weight loss on average, but individual results vary, and the Wegovy HD option narrows the gap.

Other approved uses

The two drugs carry different US Food and Drug Administration (FDA) approvals beyond weight loss.

Wegovy is also approved to lower the risk of heart attack and stroke in adults with cardiovascular disease who have either obesity or overweight. One large trial found that semaglutide (the active ingredient in Wegovy) reduced the risk of major cardiovascular events by 20% compared to placebo.

Wegovy injections are also indicated for treating a form of fatty liver disease called metabolic dysfunction-associated steatohepatitis (MASH), specifically noncirrhotic cases with moderate to advanced liver fibrosis. This is not true of the pill. 

Zepbound has its own extra approvals, too: It's cleared for treating moderate-to-severe obstructive sleep apnea in people with obesity.

Format options

Both Zepbound and Wegovy come in prefilled, single-dose injection pens. But each drug has additional formats as well.

Zepbound also comes in multi-dose KwikPens (available on Ro!) and in vials. 

Wegovy is also available as a once-daily pill, which can be a useful option for people who are needlephobic, struggle to remember a once-weekly injection, or simply prefer taking a daily pill.

The reasons for switching from Zepbound to Wegovy vary, but a few common ones come up fairly regularly.

Insurance coverage changes

Insurance plans don't always cover both medications, and coverage can change from year to year. If your plan drops Zepbound, Wegovy may still be covered, or vice versa.

Call your insurer directly before assuming a switch will save you money. Costs for both can be significant without coverage, though Ro offers both medications at the lowest available out-of-pocket costs thanks to collaborations with the drugs’ manufacturers, Eli Lilly and Novo Nordisk. 

Cost

List prices for both medications are significant, although Zepbound generally has a lower list price than Wegovy. But the list price isn't what most people actually pay. As of publications, Zepbound’s list price is $1,086.37, and Wegovy’s list price is $1,349.02. On Ro, both are available at cash-pay prices, with the Wegovy pill starting at $149 per month, the Wegovy pen at $199 per month, and the Zepbound KwikPen at $299 per month.

Find out more about your current pricing options here.

Side effects

Nausea, diarrhea, and vomiting are common with both Zepbound and Wegovy, especially at the start of treatment and after each dose increase. In the head-to-head trial, fewer people stopped Zepbound because of these side effects than stopped Wegovy (2.7% vs. 5.6%). 

How your body reacts is hard to predict, and some people simply tolerate one medication better than the other.

Cardiovascular and liver health

If you have cardiovascular disease, your healthcare provider may lean toward Wegovy. It's the only one of the two that's also approved to help reduce heart attack and stroke risk in people with obesity or carrying excess weight and who have existing cardiovascular disease.

The Wegovy injection is also cleared for treating MASH in some adults — another reason a provider might recommend switching if that's part of your health picture.

It's worth bringing your full medical history to your appointment so it can be considered alongside everything else.

Personal preference

Some people may prefer the pill option Wegovy offers and want to avoid injections long-term. And that’s a perfectly good reason to bring it up with your provider.

See if you qualify

Never stop Zepbound and start Wegovy on your own. This is a switch that needs to be reviewed, recommended, and guided by your healthcare provider. That said, here's how the process typically works.

Step 1: Talk to your healthcare provider first

Your provider will review your current dose, your health history, and your goals before advising on next steps. They'll also handle any prior authorization your insurer requires.

Step 2: Take your last Zepbound dose as normal

There's typically no need to taper off Zepbound gradually. Take your last dose on your regular injection day, then stop.

Step 3: Wait approximately one week

Because both drugs stay active in your system after your last dose — around 5–6 days for Zepbound and around seven days for injectable Wegovy — most providers recommend a gap of roughly one week before starting Wegovy. This avoids overlapping the two medications, which could increase the risk of side effects.

Step 4: Start Wegovy at a low dose

There's no direct dose conversion between Zepbound and Wegovy, as the two medications work differently and use different dosing scales. Your provider will determine the right starting dose based on your history.

If you're switching to the Wegovy pen, most providers start at 0.25 mg once weekly; if you're switching to the Wegovy pill, the starting dose is 1.5 mg once daily.

Either way, you'll work up gradually — even if you were on a higher Zepbound dose — to reduce the chance of side effects during the transition.

Step 5: Give it time

It can take a few months to reach your maintenance dose of Wegovy. Roughly four months (~16–17 weeks) on the pen, and around three months on the pill,  with continued weight loss expected beyond that. It can take extra time and patience with the injection, as some people may increase to 7.2 mg after they have been on 2.4 mg for at least four weeks and need additional weight loss.

You may notice increased appetite or food cravings during the first few weeks as Zepbound clears your system and Wegovy builds to a steady state. This is normal and typically passes as the new medication takes effect.

It’s important not to draw conclusions about how well Wegovy is working until you've been at your maintenance dose for a meaningful period. If you have any concerns, raise them with your provider, don’t stop on your own.

If you're switching because of insurance, your provider can also help make the case to your insurer if prior authorization is needed.

Whatever Zepbound dose you’re on now, you’ll restart Wegovy at its lowest dose and step up about every four weeks on the pen, and every 30 days on the pill.

With the Wegovy pen, some people may later increase beyond the 2.4 mg maintenance dose, up to a maximum of 7.2 mg once weekly, if they've tolerated 2.4 mg for at least four weeks and their provider recommends it for further weight loss.

Results vary. Some people hold onto their progress on Wegovy, while others notice slight changes. Because you restart dose escalation from the lowest step, the early GI side effects can briefly return even if Zepbound never bothered you. 

Give it real time before drawing conclusions, and if Wegovy doesn't seem to be working, check in with your provider rather than stopping or adjusting your dose on your own.

Check your coverage for FDA-approved GLP-1s—for free

Check for free

Switching from Zepbound to Wegovy is a legitimate option, but it's not a decision to take lightly. The two medications work differently, and what's right for you depends on your health history, your goals, and what your insurance will cover.

• Zepbound tends to produce greater weight loss on average, but Wegovy also has approval for cardiovascular disease and MASH, and is available as a daily pill too.

• There's no simple dose swap between the two — you'll start Wegovy at a lower dose and build up gradually.

• Side effects can return during the transition, even if you had no issues on Zepbound.

• For many people, the switch comes down to cost and coverage, not just which medication works better.

A healthcare provider can help you weigh your options and make the switch safely if it's the right move for you.